FindTrial
Sign In

Treatment of Obesity by Intraparietogastric Injection of Botulinum Toxin

Treatment of Obesity by Intraparietogastric Injection of Botulinum Toxin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000413
Enrollment
Unknown
Registered
2009-05-21
Start date
2008-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

group I:intraparietogastric injection of botulinum toxin type A 200U
group II:intraparietogastric injection of botulinum toxin type A 300U

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. simple obesity patients of BMI>=28kg/m2; 2. failed on diet,exercise and medication many times

Exclusion criteria

Exclusion criteria: endocrine obesity; taking weight-reducing aid in recent 3 months;a history of neoplasia; pregnancy (also potentially); surgery of the stomach or gastrointestinal diseases; patients with previous botulism, neurological or neuromuscular diseases; severe psychiatric illnesses (including psychotic disorders, current mood and anxiety disorders, bulimia, alcohol or substance abuse or dependence; heavy binge-eating disorder.

Design outcomes

Primary

MeasureTime frame
weight;BMI;gastric emptying time;—

Secondary

MeasureTime frame
waistline;hip circumference;blood lipids;serum leptin;plasma ghrelin;—

Countries

China

Contacts

Public ContactQingsen Liu
liuqs@msn.com+86 010 66939748

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026